Theresearchers found no significant difference in the expression of Wnt3a in relationto gender and age, as well as in relation to the degree of tumor differentiation,disease progression, evolution to death or clinical staging at diagnosis.Considering that there is no guide for reading the immunostaining, some samples thatwere considered weakly positive may have been considered negative. The gene discussed is WNT3A; the disease is neoplasm.